T Marth

Summary

Affiliation: Saarland University
Country: Germany

Publications

  1. pmc Regulation of interleukin-12 by complement receptor 3 signaling
    T Marth
    Mucosal Immunity Section, Laboratory of Clinical Investigation, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Exp Med 185:1987-95. 1997
  2. ncbi request reprint Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease
    T Marth
    Mucosal Immunity Section, National Institutes of Health, Bethesda, Maryland, USA
    Gastroenterology 113:442-8. 1997
  3. ncbi request reprint Murine model of oral tolerance. Induction of Fas-mediated apoptosis by blockade of interleukin-12
    T Marth
    Innere Medizin II, Universitatskliniken des Saarlandes, Homburg Saar, Germany
    Ann N Y Acad Sci 859:290-4. 1998
  4. ncbi request reprint Antigen-induced mucosal T cell activation is followed by Th1 T cell suppression in continuously fed ovalbumin TCR-transgenic mice
    T Marth
    Innere Medizin II, Universitatskliniken des Saarlandes, Homburg Saar, Germany
    Eur J Immunol 30:3478-86. 2000
  5. ncbi request reprint Decreased levels of interleukin-12p40 in the serum of patients with Whipple's disease
    A Kalt
    Department of Dermatology, The University of the Saarland, 66421, Homburg Saar, Germany
    Int J Colorectal Dis 21:114-20. 2006
  6. ncbi request reprint Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation
    W Strober
    Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA
    Immunol Today 18:61-4. 1997
  7. ncbi request reprint Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production
    R A Seder
    Lymphokine Regulation Unit, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 160:5719-28. 1998
  8. ncbi request reprint [Anti-inflammatory properties of interleukin-10 in human Crohn's disease: much to learn, much to explore]
    A Stallmach
    Innere Medizin II, Universitatskliniken des Saarlandes, Germany
    Z Gastroenterol 40:475-7. 2002

Detail Information

Publications8

  1. pmc Regulation of interleukin-12 by complement receptor 3 signaling
    T Marth
    Mucosal Immunity Section, Laboratory of Clinical Investigation, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Exp Med 185:1987-95. 1997
    ..Our studies thus define a novel role for CR3 in regulating CMI functions via IL-12...
  2. ncbi request reprint Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease
    T Marth
    Mucosal Immunity Section, National Institutes of Health, Bethesda, Maryland, USA
    Gastroenterology 113:442-8. 1997
    ..The aim of this study was to test whether this macrophage dysfunction is the cause or result of previously shown T-cell defects...
  3. ncbi request reprint Murine model of oral tolerance. Induction of Fas-mediated apoptosis by blockade of interleukin-12
    T Marth
    Innere Medizin II, Universitatskliniken des Saarlandes, Homburg Saar, Germany
    Ann N Y Acad Sci 859:290-4. 1998
    ..A combination of oral antigen feeding and administration of anti-IL-12 may thus be useful in the treatment of autoimmune diseases and may be a potent means to modulate peripheral tolerance...
  4. ncbi request reprint Antigen-induced mucosal T cell activation is followed by Th1 T cell suppression in continuously fed ovalbumin TCR-transgenic mice
    T Marth
    Innere Medizin II, Universitatskliniken des Saarlandes, Homburg Saar, Germany
    Eur J Immunol 30:3478-86. 2000
    ..These data further define the regulation of suppressive immune functions following antigen feeding in the periphery and the mucosal immune system...
  5. ncbi request reprint Decreased levels of interleukin-12p40 in the serum of patients with Whipple's disease
    A Kalt
    Department of Dermatology, The University of the Saarland, 66421, Homburg Saar, Germany
    Int J Colorectal Dis 21:114-20. 2006
    ..It is unclear whether this defect of cellular immunity is translated to the humoral immune system and to serum correlates...
  6. ncbi request reprint Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation
    W Strober
    Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA
    Immunol Today 18:61-4. 1997
    ..Interventions that artificially bring the excessive Th1-cell response back into balance, such as administration of IL-12 antagonists, should therefore find a central place in the treatment of the disease...
  7. ncbi request reprint Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production
    R A Seder
    Lymphokine Regulation Unit, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 160:5719-28. 1998
    ..Finally, the addition of exogenous TGF-beta to priming cultures significantly enhanced the production of TGF-beta upon restimulation, demonstrating that TGF-beta has a role in self-regulating its own production...
  8. ncbi request reprint [Anti-inflammatory properties of interleukin-10 in human Crohn's disease: much to learn, much to explore]
    A Stallmach
    Innere Medizin II, Universitatskliniken des Saarlandes, Germany
    Z Gastroenterol 40:475-7. 2002